Rockville, MD — OriGene Technologies, a global leader in gene-centric research tools, today announced an exclusive distributorship and a co-marketing partnership with Nanoportal Biotech for ProteanFect™, an industry-first, coacervate-based gene delivery reagent that promises to redefine transfection in challenging cell types. ProteanFect represents a major leap forward in nucleic acid delivery. Unlike conventional lipid- or polymer-based […]
Funding will accelerate commercialization of its breakthrough biomarker detection platform MUSE®. Oberkochen, Germany | ZEISS Group ZEISS Ventures participated in an oversubscribed financing round of CHF 6.3 million for arcoris bio, a Swiss start-up specializing in a platform technology aimed at enhancing biomolecule detection and imaging for spatial multiomics solutions. The funding round, co-led by […]
Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing Cambridge, UK, and Lausanne, Switzerland — SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and Alithea Genomics, a pioneer in the field of large-scale RNA sequencing […]
CAMBRIDGE, England — Novogene Europe is pleased to announce the launch of its new Whole Plasmid Sequencing service, powered by Oxford Nanopore Technologies (ONT). This service offering represents a major step forward in plasmid verification, providing researchers with a powerful and practical alternative to traditional Sanger sequencing. Unlike conventional approaches, whole plasmid sequencing delivers a […]
Atinary collaborates with ABB Robotics, Mettler-Toledo, and Agilent to launch the first Self-Driving Lab of its kind in accelerating molecular discovery. We are thrilled to announce Atinary’s collaboration with ABB Robotics to build our first Self-Driving Lab for small-molecule synthesis. The new Atinary Lab will be in Boston. This project brings together Atinary’s pioneering AI-driven platform with […]
Nightingale Health (Nasdaq Helsinki: HEALTH; OTCQX: NHLTY, NGHLF), a pioneer in disease risk detection and global leader in metabolomics, announces a strategic partnership with Alamar Biosciences to integrate cutting-edge brain health proteomics into its multiomics portfolio. This collaboration enables comprehensive multiomics analysis from a single blood sample – available only from Nightingale Health. Nightingale Health’s […]
Ginkgo and Partners to Develop Monoclonal Antibody Biomanufacturing Innovations and to Produce an Anti-Filovirus Medical Countermeasure BOSTON — Ginkgo Bioworks (NYSE: DNA) announced today that it has been awarded a contract through the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) to develop innovations that strengthen and reduce the costs of domestic […]
NMPA approval on the Sequel II CNDx system enables clinicians in China to harness PacBio HiFi sequencing for challenging conditions, with initial offering for thalassemia MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry Genomics, the Sequel II CNDx system […]
BioPAT® Viamass provides high resolution real-time viable capacitance-based biomass measurement directly in the cell culture, enabling direct inline monitoring of cell growth and advanced, precise analysis Seamless scalability with one biomass monitoring method from small-scale Ambr® experiments through to large-scale single-use Biostat STR® or Biostat® RM runs The BioPAT® Viamass single-use sensor integrated with Ambr® […]
Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux, a world leader in the field of in vitro diagnostics, have announced the launch of AmPORE-TB, a Research Use Only* (RUO) solution for the rapid characterisation of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis complex, using Oxford Nanopore […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
